Navigation Links
Scent To Sleep Offers Help for Companies Losing Time, Money to Microsleep
Date:11/20/2008

ps the user mentally and physically prepare for sleep by becoming more relaxed. Application is easy; the user simply sprays his or her pillows, bed linens and pajamas shortly before turning in for the night. There are no side effects, and users report waking up rested and refreshed in the morning, sometimes for the first time in weeks or months.

"My insomnia is gone, [and] I'm sleeping through the night," said Cherie Elkins, a Scent To Sleep user in Columbus, Ohio. "I'm finally feeling like myself again!"

Scent To Sleep is available in Luscious Lavender and Decadent Green Apple Vanilla scents. The company offers a 30-day satisfaction guarantee, making Scent To Sleep a risk-free way for companies to reduce errors and absenteeism while showing employees they care.

Scent To Sleep can ship its sleep mist directly to a company or to employees' homes. Businesses interested in taking advantage of the employer discount can e-mail the company at info@scenttosleep.com for the discounted invoice. Learn more at http://www.scenttosleep.com.

    Contact:
    Marina Brown-Ihim
    Scent To Sleep
    909-244-7257
    marina@scenttosleep.com
   http://www.scenttosleep.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Scent To Sleep
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. New CT technology shows anorexia impairs adolescent bone development
2. Families, friends, schools and neighborhoods contribute to adolescent alcohol misuse
3. The HealthCentral Networks MyDiabetesCentral.com Launches Interactive Resource to Promote Awareness of Diabetes
4. Flu vaccination rates lag for at-risk adolescents
5. Capella University Offers New MS in Psychology Specialization in Child and Adolescent Development : Capella is the only regionally accredited online university to offer this master's specialization
6. Truck Donation to Convalescent Aid Society of Pasadena
7. MBL scientist Osamu Shimomura wins Nobel Prize for discovery of green fluorescent protein
8. Adolescent insomnia linked to depression and substance abuse during adolescence and young adulthood
9. Newer antipsychotics no better than older drug in treating child and adolescent schizophrenia
10. ScentToSleep.com Is Pleased to Announce That the Company Was Featured in the September 15th Issue of Womans World Magazine
11. Participating in religion may make adolescents from certain races more depressed
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3Disrupting a destructive duo 3A U of T Mississauga researchers inhibit cancer proteins 9634 1Disrupting a destructive duo 3A U of T Mississauga researchers inhibit cancer proteins 9634 2Ochsner and Rouses Markets Partner for Choose Healthy Initiative 54965 1Ochsner and Rouses Markets Partner for Choose Healthy Initiative 54965 2Ochsner and Rouses Markets Partner for Choose Healthy Initiative 54965 3Nostrils Compete to Relay Key Fragrance 54963 1Nostrils Compete to Relay Key Fragrance 54963 2